Skip to main content
Log in

The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures

  • Gastrointestinal
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To assess the added value of diffusion-weighted imaging (DWI) to conventional magnetic resonance imaging (MRI) for differentiating benign from malignant bile duct strictures.

Methods

Twenty-seven patients with a benign stricture and 42 patients with a malignant stricture who had undergone gadoxetic acid-enhanced MRI with DWI were enrolled. Qualitative (signal intensity, dynamic enhancement pattern) and quantitative (wall thickness and length) analyses were performed. Two observers independently reviewed a set of conventional MRI and a combined set of conventional MRI and DWI, and receiver operating characteristic (ROC) curve analysis was assessed.

Results

Benign strictures showed isointensity (18.5–70.4 %) and a similar enhancement pattern (22.2 %) to that of normal bile duct more frequently than malignant strictures (0–40.5 % and 0 %) on conventional MRI (P < 0.05). Malignant strictures (90.5–92.9 %) showed hypervascularity on arterial and portal venous phase images more frequently than benign strictures (37.0–70.4 %) (P < 0.01) On DWI, all malignant strictures showed hyperintensity compared with benign cases (70.4 %) (P < 0.001). Malignant strictures were significantly thicker and longer than benign strictures (P < 0.001). The diagnostic performance of both observers improved significantly after additional review of DWI.

Conclusions

Adding DWI to conventional MRI is more helpful for differentiating benign from malignant bile duct strictures than conventional MRI alone.

Key points

• Accurate diagnosis and exclusion of benign strictures of bile duct are important.

• Diffusion-weighted MRI helps to distinguish benign from malignant bile duct strictures.

• DWI plus conventional MRI provides superior diagnostic accuracy to conventional MRI alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Fulcher AS, Turner MA, Capps GW, Zfass AM, Baker KM (1998) Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects. Radiology 207:21–32

    CAS  PubMed  Google Scholar 

  2. Park MS, Kim TK, Kim KW et al (2004) Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 233:234–240

    Article  PubMed  Google Scholar 

  3. Worawattanakul S, Semelka RC, Noone TC, Calvo BF, Kelekis NL, Woosley JT (1998) Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging 16:993–1003

    Article  CAS  PubMed  Google Scholar 

  4. Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ (1997) Cholangiocarcinoma: a review. Gastroenterologist 5:306–315

    CAS  PubMed  Google Scholar 

  5. Lee WJ, Lim HK, Jang KM et al (2001) Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 21:97–116

    Article  Google Scholar 

  6. Kim JY, Lee JM, Han JK et al (2007) Contrast-enhanced MRI combined with MR cholangiopancreatography for the evaluation of patients with biliary strictures: differentiation of malignant from benign bile duct strictures. J Magn Reson Imaging 26:304–312

    Article  PubMed  Google Scholar 

  7. Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254:47–66

    Article  PubMed  Google Scholar 

  9. Parikh T, Drew SJ, Lee VS et al (2008) Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 246:812–822

    Article  PubMed  Google Scholar 

  10. Fulcher AS, Turner MA, Zfass AM (1998) Magnetic resonance cholangiopancreatography: a new technique for evaluating the biliary tract and pancreatic duct. Gastroenterologist 6:82–87

    CAS  PubMed  Google Scholar 

  11. Soto JA, Alvarez O, Lopera JE, Munera F, Restrepo JC, Correa G (2000) Biliary obstruction: findings at MR cholangiography and cross-sectional MR imaging. Radiographics 20:353–366

    Article  CAS  PubMed  Google Scholar 

  12. Soyer P, Bluemke DA, Reichle R et al (1995) Imaging of intrahepatic cholangiocarcinoma: 2. Hilar cholangiocarcinoma. AJR Am J Roentgenol 165:1433–1436

    Article  CAS  PubMed  Google Scholar 

  13. Schulte SJ, Baron RL, Teefey SA et al (1990) CT of the extrahepatic bile ducts: wall thickness and contrast enhancement in normal and abnormal ducts. AJR Am J Roentgenol 154:79–85

    Article  CAS  PubMed  Google Scholar 

  14. Lacomis JM, Baron RL, Oliver JH 3rd, Nalesnik MA, Federle MP (1997) Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 203:98–104

    CAS  PubMed  Google Scholar 

  15. Park HS, Lee JM, Kim SH et al (2006) CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. AJR Am J Roentgenol 187:445–453

    Article  PubMed  Google Scholar 

  16. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174

    Article  CAS  PubMed  Google Scholar 

  17. Park MS, Yu JS, Kim KW et al (2001) Recurrent pyogenic cholangitis: comparison between MR cholangiography and direct cholangiography. Radiology 220:677–682

    Article  CAS  PubMed  Google Scholar 

  18. Koga A, Ichimiya H, Yamaguchi K, Miyazaki K, Nakayama F (1985) Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance. Cancer 55:2826–2829

    Article  CAS  PubMed  Google Scholar 

  19. Park KW, Lim JH, Jang KT, Choi DW (2008) Autoimmune cholangitis mimicking periductal-infiltrating cholangiocarcinoma. Abdom Imaging 33:334–336

    Article  PubMed  Google Scholar 

  20. Chung DT, Tang CN, Lai EC, Yang GP, Li MK (2010) Immunoglobulin G4-associated sclerosing cholangitis mimicking cholangiocarcinoma. Hong Kong Med J 16:149–152

    CAS  PubMed  Google Scholar 

  21. Finkelberg DL, Sahani D, Deshpande V, Brugge WR (2006) Autoimmune pancreatitis. N Engl J Med 355:2670–2676

    Article  CAS  PubMed  Google Scholar 

  22. Nishino T, Toki F, Oyama H et al (2005) Biliary tract involvement in autoimmune pancreatitis. Pancreas 30:76–82

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seong Hyun Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, H.J., Kim, S.H., Jang, K.M. et al. The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures. Eur Radiol 24, 947–958 (2014). https://doi.org/10.1007/s00330-014-3097-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-014-3097-x

Keywords

Navigation